| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/24/2002 | EP1198568A1 Compositions and methods for the treatment of immune related diseases |
| 04/24/2002 | EP1198464A1 8-PHENYL-6,9-DIHYDRO- 1,2,4]TRIAZOLO 3,4- i i /i ]PURIN-5-ONE DERIVATIVES |
| 04/24/2002 | EP1198256A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 04/24/2002 | EP1198246A2 Methods for preventing or attenuating pathoangiogenic conditions by using the gbs-toxin (cm101) receptor as a vaccine |
| 04/24/2002 | EP1198241A1 Novel proteins |
| 04/24/2002 | EP1198232A1 Urea substituted imidazoquinolines |
| 04/24/2002 | EP1198223A2 Ophthalmic composition comprising ketotifen |
| 04/24/2002 | CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4 |
| 04/24/2002 | CN1346344A Substituted 2-aminobenzamide caspase ihibitors and the use thereof |
| 04/24/2002 | CN1346271A Quinazoline derivatives as angiogenesis inhibitors |
| 04/24/2002 | CN1346270A Compositions having improved stability |
| 04/24/2002 | CA2359606A1 Cysteine/glycine rich peptides |
| 04/23/2002 | US6376672 Restenosis; vision defects; cardiovascular disorders; kidney dieases |
| 04/23/2002 | US6376665 Antiarthritic agents, antiinflammatory agents |
| 04/23/2002 | US6376653 Tie2 antagonist antibodies |
| 04/23/2002 | US6376541 Topical administering |
| 04/23/2002 | US6376519 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 04/23/2002 | US6376518 Anticarcinogenic agents; side effect reduction |
| 04/23/2002 | US6376517 For treating vision loss, preventing vision degeneration, and promoting vision regeneration (?neopsis?) |
| 04/23/2002 | US6376496 Inhibitors of prenyl-protein transferase |
| 04/23/2002 | US6376495 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 04/23/2002 | US6376489 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/23/2002 | US6376242 Reduce the number of circulating platelets to low or below normal levels. |
| 04/23/2002 | US6375973 Olopatadine and emedastine and an ophthalmically acceptable polymeric quaternary ammonium compound as a preservative |
| 04/23/2002 | US6375972 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 04/23/2002 | US6375960 Nanoemulsion based on ethoxylated fatty ethers or on ethoxylated fatty esters and its uses in the cosmetics, dermatological and/or ophthalmological fields |
| 04/23/2002 | US6375929 Gene therapy for inhibition of angiogenesis |
| 04/23/2002 | CA2246727C Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 04/23/2002 | CA2072148C Tissue moisturizing composition and method |
| 04/23/2002 | CA2042934C Treatment of ocular hypertension with an ocular synergistic combination |
| 04/18/2002 | WO2002030982A2 Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use |
| 04/18/2002 | WO2002030938A1 Benzhydryl derivatives |
| 04/18/2002 | WO2002030933A1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines |
| 04/18/2002 | WO2002030924A1 Quinazoline derivatives with anti-tumour activity |
| 04/18/2002 | WO2002030910A1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 04/18/2002 | WO2002030908A1 Inhibitors of protein kinases |
| 04/18/2002 | WO2002030898A1 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
| 04/18/2002 | WO2002030888A2 Tricyclic compounds and uses thereof |
| 04/18/2002 | WO2002030881A1 Sulfonylguanidine |
| 04/18/2002 | WO2002030873A1 Mmp inhibitor |
| 04/18/2002 | WO2002030473A1 Targeted therapeutic agents |
| 04/18/2002 | WO2002030444A2 Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery |
| 04/18/2002 | WO2002030420A1 Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof |
| 04/18/2002 | WO2002030395A1 Topical antibiotic composition for treatment of eye infection |
| 04/18/2002 | WO2002017914A3 Fused pyrrolocarbazoles against inflammation |
| 04/18/2002 | WO2002008217A3 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 04/18/2002 | WO2001082952A3 USE OF α-MSH AND EPO FOR PREVENTING OR TREATING ISCHEMIC CONDITIONS |
| 04/18/2002 | WO2001072777A3 Human transcription factors |
| 04/18/2002 | WO2001068570A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001068569A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001068075A3 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 04/18/2002 | WO2001068070A3 Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis |
| 04/18/2002 | WO2001058893A3 Indol-3-yl derivatives and their use as integrin inhibitors |
| 04/18/2002 | WO2000073482A9 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
| 04/18/2002 | US20020045759 E.g., N-(2-Phenylsulfonyl-1-ethyl)-3-(4-Cyanophenyl)-2,3-dihydro-imidazo(2,1 -b)thiazole-5-carboxamide hydrochloride; treating cancer, neurofibromin benign proliferative disorder, retinal vascularization, and hepatitis delta |
| 04/18/2002 | US20020045660 For enhancing neurological development of preterm infants; arachidonic acid and/or docosahexaenoic acid; enhances visual, language and motor development without anthropomethric growth inhibition |
| 04/18/2002 | US20020045645 Lactone integrin antagonists |
| 04/18/2002 | US20020045642 Antiinflammatory, -arthritic and -emetic agents; central nervous system disorders; Parkinson's disease; antidepressants; psychological disorders; anxiolytic agents; antagonists of substance P receptors |
| 04/18/2002 | US20020045635 Novel mGluR antagonists and a method for their synthesis |
| 04/18/2002 | US20020045623 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 04/18/2002 | US20020045613 1-aroyl-piperidinyl benzamidines |
| 04/18/2002 | US20020045601 Ophthalmic compositions |
| 04/18/2002 | US20020045568 Use of mp52 0r mp121 for treating and preventing diseases of the nervous system |
| 04/18/2002 | US20020045213 IL-17 receptor like molecules and uses thereof |
| 04/18/2002 | US20020045203 Method for detecting active ingredients of medical value |
| 04/18/2002 | US20020044936 Administering a monoclonal antibody or fragment thereof which acts as an antagonist of the integrins GPIIb/IIIa ( alpha IIb beta 3) and alpha v beta 3; also treating inflammatory diseases such as rheumatoid arthritis, psoriasis |
| 04/18/2002 | DE10050662A1 New substituted dihydropyrido-pyrimidine derivatives, useful for treating e.g. pain, urinary incontinence and tinnitus |
| 04/18/2002 | DE10050661A1 New substituted 3,4-dihydro-pyrimido(1,2-a)pyrimidine and 3,4-dihydro-pyrazino(1,2-a)pyrimidine derivatives useful for the treatment of pain, urinary incontinence, pruritis, tinnitus and diarrhea |
| 04/18/2002 | CA2425666A1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines |
| 04/18/2002 | CA2425508A1 Targeted therapeutic agents |
| 04/18/2002 | CA2424585A1 Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof |
| 04/18/2002 | CA2424444A1 Topical antibiotic composition for treatment of eye infection |
| 04/18/2002 | CA2424292A1 Tricyclic compounds and uses thereof |
| 04/18/2002 | CA2424107A1 Sulfonylguanidines |
| 04/18/2002 | CA2423595A1 Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery |
| 04/18/2002 | CA2394084A1 Inhibitors of protein kinases |
| 04/17/2002 | EP1197550A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 04/17/2002 | EP1197488A1 (2S)-2-(Adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 04/17/2002 | EP1197484A2 1H-Indole-3-glyoxylamide sPLA2 inhibitors |
| 04/17/2002 | EP1197223A1 Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy |
| 04/17/2002 | EP1196577A2 Cell cycle and proliferation proteins |
| 04/17/2002 | EP1196568A1 Human lim domain proteins |
| 04/17/2002 | EP1196441A1 Keratinocyte growth factor-2 |
| 04/17/2002 | EP1196440A2 Therapeutic peptides derived from subsequences of bpi |
| 04/17/2002 | EP1196407A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors |
| 04/17/2002 | EP1196404A1 Piperazine derivatives as modulators of chemokine receptor activity |
| 04/17/2002 | EP1196397A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 04/17/2002 | EP1196395A1 Cyclized amino acid derivatives |
| 04/17/2002 | EP1196391A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
| 04/17/2002 | EP1196386A2 N-substituted glycine derivatives |
| 04/17/2002 | EP1196186A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 04/17/2002 | EP1196180A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 04/17/2002 | EP1196167A1 Method of reducing neuronal injury or apoptosis |
| 04/17/2002 | EP1196166A1 Azetidine carboxamide derivatives for the treatment of cns disorders |
| 04/17/2002 | EP1196165A2 Azetidine compounds in cns and eye diseases |
| 04/17/2002 | EP1196162A1 Procyanidin oligomers for inhibiting matrix metalloproteinases and medicine having effective composition of same |
| 04/17/2002 | EP1196159A1 Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 04/17/2002 | EP0915702B1 Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
| 04/17/2002 | EP0901378B1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid |
| 04/17/2002 | EP0740550B1 Use of mometasone furoate for treating airway passage and lung diseases |